Unplanned Return to the Operating Room in Orthopaedics: Closed-Loop Quality Improvement Programme (UROR-LOOP)
Effectiveness of a Hospital-Level Closed-Loop Management System for Unplanned Return to the Operating Room in Orthopaedics: A Multicentre, Prospective, Before-and-After Quality Improvement Study
Обзор исследования
Статус
Статус
Условия
Условия
Вмешательство/лечение
Вмешательство/лечение
Подробное описание
Тип исследования
Тип исследования
Регистрация (Оцененный)
Регистрация
Фаза
Фаза
- Непригодный
Контакты и местонахождение
Контакты исследования
Контакты исследования
- Имя: Haixue Wang
- Номер телефона: +8613041196856
- Электронная почта: gwwanghaixue@126.com
Критерии участия
Критерии приемлемости
Критерии приемлемости
Возраст, подходящий для обучения
- Ребенок
- Взрослый
- Пожилой взрослый
Принимает здоровых добровольцев
Описание
Inclusion Criteria:
- A public secondary or tertiary general hospital or specialty hospital in China.
- Has an independent orthopaedic ward and an established orthopaedic surgical team.
- Has performed at least 2,000 orthopaedic surgical procedures per year during each of the previous three years.
- Is willing to participate in the study and sign the study cooperation agreement.
- The head of the orthopaedic department, or an authorized departmental representative, is willing to provide written informed consent on behalf of the participating department.
- Has accessible hospital discharge records, surgical and anaesthesia information systems, and the information infrastructure required for data verification.
- Is able to provide the required aggregated and de-identified study data and complete the scheduled follow-up assessments.
Exclusion Criteria:
- Is currently conducting a similar quality improvement programme that may affect the evaluation of the study intervention.
- Is unable to complete the required follow-up assessments or data reporting.
- Experiences or is expected to experience major institutional restructuring during the study period that may substantially affect implementation of the intervention.
The unit of enrollment, intervention, and analysis is the participating hospital and its orthopaedic department. Individual patients are not recruited as research participants. Only aggregated and de-identified hospital-level data will be collected.
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Профилактика
- Распределение: Н/Д
- Интервенционная модель: Одногрупповое задание
- Маскировка: Нет (открытая этикетка)
Количество рук
Оружие и интервенции
Группа участников / АрмияГруппа участников / Армия |
Вмешательство/лечениеВмешательство/лечение |
|---|---|
|
Экспериментальный: Closed-Loop Management Programme for UROR in Orthopaedics
Participating orthopaedic departments will first undergo a baseline assessment of their existing management and reporting practices for unplanned return to the operating room.
They will then implement a standardized hospital-level closed-loop quality improvement programme.
The programme includes standardizing the definition of unplanned return to the operating room, establishing a non-punitive reporting mechanism, appointing a departmental coordinator, conducting multi-source data verification, organizing regular department-wide case reviews and root-cause analyses, and developing and implementing continuous quality improvement actions.
Implementation fidelity will be assessed quarterly, and study outcomes will be evaluated every six months during the 36-month study period.
|
This hospital-level organizational and behavioral quality improvement intervention aims to improve the management of unplanned return to the operating room in orthopaedics.
Following standardized training and system establishment, participating departments will implement a closed-loop management programme comprising six components: a standardized definition; a non-punitive reporting mechanism; appointment of a departmental coordinator; monthly case registration and multi-source verification using departmental records, adverse-event reporting systems, medical records, and surgical or anaesthesia information systems; regular department-wide case review and root-cause analysis; and development, implementation, and follow-up of continuous improvement actions.
The programme will operate continuously, with monthly management activities and quarterly adherence assessments.
It does not alter clinical treatment or require additional diagnostic or therapeutic procedures.
|
Что измеряет исследование?
Первичные показатели результатов
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Underreporting Rate of Unplanned Return to the Operating Room in Orthopaedics
Временное ограничение: Baseline and 12, 24, and 36 months after implementation
|
The percentage of verified cases of unplanned return to the operating room (UROR) that were not reported through the designated hospital reporting pathway during each assessment period.
UROR cases will be identified and verified by cross-checking departmental case registries, hospital adverse-event reporting systems, medical records, and surgical or anaesthesia information systems.
The underreporting rate will be calculated as the number of verified UROR cases not formally reported divided by the total number of verified UROR cases, multiplied by 100%.
|
Baseline and 12, 24, and 36 months after implementation
|
|
Implementation Rates of Predefined Closed-Loop Management Components
Временное ограничение: Baseline and 12, 24, and 36 months after implementation
|
At each assessment, the implementation rate of each prespecified closed-loop management component will be calculated separately as the number of participating orthopaedic departments meeting the component-specific implementation criterion divided by the total number of departments assessed, multiplied by 100%.
Components include: appointment of a designated departmental coordinator; completion of a standardized UROR case registry; multi-source case verification; completion of standardized case-review records; department-wide review of verified UROR cases; and documented development, implementation, and follow-up of quality improvement actions.
Results will be reported separately for each component.
|
Baseline and 12, 24, and 36 months after implementation
|
Вторичные показатели результатов
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Rate of Unplanned Return to the Operating Room in Orthopaedics
Временное ограничение: Baseline and 12, 24, and 36 months after implementation
|
The percentage of orthopaedic surgical procedures followed by a verified unplanned return to the operating room during each assessment period.
The rate will be calculated as the number of verified UROR cases divided by the total number of orthopaedic surgical procedures performed during the same period, multiplied by 100%.
A verified UROR includes an unplanned repeat operation within 31 days of the original procedure, during the same hospitalization or following readmission, and excludes preplanned staged procedures.
|
Baseline and 12, 24, and 36 months after implementation
|
|
Rates of Predefined Postoperative Complications in Orthopaedics
Временное ограничение: Baseline and 12, 24, and 36 months after implementation
|
The percentage of orthopaedic surgical patients experiencing each prespecified postoperative complication during the assessment period.
Complications include bleeding or haematoma, surgical site or other postoperative infection, venous thromboembolism, implant-related complications, drainage-related complications, and other protocol-defined complications.
The rate for each complication will be calculated separately as the number of patients with the complication divided by the total number of orthopaedic surgical patients, multiplied by 100%.
|
Baseline and 12, 24, and 36 months after implementation
|
|
Unplanned Readmission Rate After Orthopaedic Surgery
Временное ограничение: Baseline and 12, 24, and 36 months after implementation
|
The percentage of orthopaedic surgical patients who experience an unplanned readmission after discharge during the prespecified follow-up period.
The rate will be calculated as the number of patients with an unplanned readmission divided by the total number of discharged orthopaedic surgical patients eligible for assessment, multiplied by 100%.
|
Baseline and 12, 24, and 36 months after implementation
|
|
Mean Length of Hospital Stay Among Orthopaedic Surgical Patients
Временное ограничение: Baseline and 12, 24, and 36 months after implementation
|
The hospital-level mean length of stay among orthopaedic surgical patients during each assessment period.
Length of stay will be calculated from the date of hospital admission to the date of discharge and summarized in days using aggregated hospital-level data.
|
Baseline and 12, 24, and 36 months after implementation
|
|
Mean Hospitalization Cost Among Orthopaedic Surgical Patients
Временное ограничение: Baseline and 12, 24, and 36 months after implementation
|
The hospital-level mean total hospitalization cost among orthopaedic surgical patients during each assessment period.
Total hospitalization cost will be obtained from the participating hospital's standardized administrative or medical record data and reported using aggregated hospital-level data in Chinese yuan.
|
Baseline and 12, 24, and 36 months after implementation
|
Соавторы и исследователи
Спонсор
Спонсор
Даты записи исследования
Изучение основных дат
Начало исследования (Оцененный)
Начало исследования
Первичное завершение (Оцененный)
Первичное завершение
Завершение исследования (Оцененный)
Завершение исследования
Даты регистрации исследования
Первый отправленный
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Первый опубликованный
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее опубликованное обновление
Последнее отправленное обновление, отвечающее критериям контроля качества
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
Другие идентификационные номера исследования
- PKUTH-ORTHO-UROR-M20260618
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .